NCT01677104View on ClinicalTrials.gov

The Microvascular Function of GLP-1 and Its Analogues

NACompletedINTERVENTIONAL

Enrollment

63

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Type 2 DiabetesObesity

Interventions

DRUG

GLP-1

GLP-1 and its analogues will be compared with placebo with and without prior DPP-IV inhibition

DRUG

Placebo

Trial Locations (1)

EX2 5AX

Diabetes and Vascular Center, Exeter

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Diabetes UK

OTHER

lead

Katarina Kos

OTHER